Human Genome Epidemiology Literature Finder
Records 1 - 3 (of 3 Records) |
Query Trace: Syndrome and ADCY9[original query] |
---|
The impact of drug metabolizing enzyme polymorphisms on outcomes after antenatal corticosteroid use. American journal of obstetrics and gynecology 2012 May 206 (5): 447.e17-24. Haas David M, Lehmann Amalia S, Skaar Todd, Philips Santosh, McCormick Catherine L, Beagle Kyle, Hebbring Scott J, Dantzer Jessica, Li Lang, Jung Jees |
CETP: Pharmacogenomics-Based Response to the CETP Inhibitor Dalcetrapib. Arteriosclerosis, thrombosis, and vascular biology 2017 Mar 37 (3): 396-400. Tardif Jean-Claude, Rhainds David, Rhéaume Eric, Dubé Marie-Pier |
Pharmacogenetics-guided dalcetrapib therapy after an acute coronary syndrome: the dal-GenE trial. European heart journal 2022 Jul . Tardif Jean Claude, Pfeffer Marc A, Kouz Simon, Koenig Wolfgang, Maggioni Aldo P, McMurray John J V, Mooser Vincent, Waters David D, Grégoire Jean C, L'Allier Philippe L, Wouter Jukema J, White Harvey D, Heinonen Therese, Black Donald M, Laghrissi-Thode Fouzia, Levesque Sylvie, Guertin Marie Claude, Dubé Marie Pierre, |
- Page last reviewed:Feb 1, 2024
- Content source: